Deoxycholic acid modified-carboxymethyl curdlan conjugate as a novel carrier of epirubicin: in vitro and in vivo studies.
作者:
主题词
动物(Animals);抗生素类, 抗肿瘤(Antibiotics, Antineoplastic);细胞系, 肿瘤(Cell Line, Tumor);细胞存活(Cell Survival);脱氧胆酸(Deoxycholic Acid);药物载体(Drug Carriers);药物调剂(Drug Compounding);表柔比星(Epirubicin);流式细胞术(Flow Cytometry);人类(Humans);氢离子浓度(Hydrogen-Ion Concentration);男(雄)性(Male);黑色素瘤, 实验性(Melanoma, Experimental);小鼠(Mice);小鼠, 近交C57BL(Mice, Inbred C57BL);显微镜检查, 共焦(Microscopy, Confocal);分子结构(Molecular Structure);纳米粒子(Nanoparticles);粒子大小(Particle Size);溶解度(Solubility);组织分布(Tissue Distribution);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays);β葡聚糖类(beta-Glucans)
DOI
10.1016/j.ijpharm.2010.03.044
PMID
20347028
发布时间
2013-11-21
- 浏览3
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文